Primary Bioscience Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 7

Primary Bioscience General Information

Description

Developer of a protein sequencing instrument designed for end-to-end protein reading. The company's device performs unbiased sequencing of every protein in a sample, including hard-to-detect variations such as single-residue substitutions, splice variants, and post-translational truncations, enabling clients and the healthcare sector to get nanopore-based, single-molecule protein sequencing technology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 7335 14th Avenue Northwest
  • Seattle, WA 98117
  • United States
+1 (414)
Primary Industry
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 7335 14th Avenue Northwest
  • Seattle, WA 98117
  • United States
+1 (414)

Primary Bioscience Timeline

202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Primary Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 14-Jul-2026 Completed Generating Revenue
5. Early Stage VC 23-Jun-2026 Completed Generating Revenue
4. Seed Round 12-Sep-2025 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Grant 01-Oct-2023 $25K Completed Generating Revenue
To view Primary Bioscience’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Primary Bioscience Patents

Primary Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026090007-A2 Systems and methods for analyte processing Pending 21-Oct-2024
WO-2026090007-A3 Systems and methods for analyte processing Pending 21-Oct-2024

Primary Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Primary Bioscience Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Activate Global Accelerator/Incubator
IndieBio Accelerator/Incubator Minority
Reinforced Ventures Venture Capital Minority
SOSV Venture Capital Minority
Creative Destruction Lab Accelerator/Incubator
You’re viewing 5 of 7 investors. Get the full list »

Primary Bioscience FAQs

  • When was Primary Bioscience founded?

    Primary Bioscience was founded in 2023.

  • Where is Primary Bioscience headquartered?

    Primary Bioscience is headquartered in Seattle, WA.

  • What is the size of Primary Bioscience?

    Primary Bioscience has 7 total employees.

  • What industry is Primary Bioscience in?

    Primary Bioscience’s primary industry is Other Devices and Supplies.

  • Is Primary Bioscience a private or public company?

    Primary Bioscience is a Private company.

  • What is Primary Bioscience’s current revenue?

    The current revenue for Primary Bioscience is .

  • How much funding has Primary Bioscience raised over time?

    Primary Bioscience has raised $3.3M.

  • Who are Primary Bioscience’s investors?

    Activate Global, IndieBio, Reinforced Ventures, SOSV, and Creative Destruction Lab are 5 of 7 investors who have invested in Primary Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process